Advertisement
Journal Home
Search for

Volume 24, Issue 4, Pages 223-228 (July 2010)


View previous. 3 of 12 View next.

Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes

Jakob GrauslundaCorresponding Author Informationemail address, Trine M.M. Jørgensenb, Mads Nybob, Anders Greencd, Lars M. Rasmussenb, Anne Katrin Sjøliea

Received 11 March 2009; accepted 12 May 2009. published online 06 July 2009.

Abstract 

Aims

The purpose of this study is to evaluate the effect of glycemic regulation, dyslipidemia, and renal dysfunction on mortality (all-cause and cardiovascular) and ischemic heart disease (IHD) in a long-term follow-up of a population-based cohort of Danish type 1 diabetic patients with at least 20 years of diabetes.

Methods

A population-based cohort of type 1 diabetic patients was identified as of July 1, 1973 (n=727). In 1993 to 1996, the cohort was reassessed and baseline data were collected from blood and urine samples in 389 patients. Mean (glycemic regulation and lipids) and highest values (creatinine and albuminuria) of the baseline period were used to predict mortality and IHD between baseline and 2006. Data of mortality and morbidity were provided by the Danish Civil Registration System, the Danish Causes of Death Registry, and the Danish National Patient Registry.

Results

At the follow-up in 2006, 256 patients (65.8%) were still alive. In a statistical model adjusted for age, sex and duration of diabetes, the following parameters were related to all-cause mortality and cardiovascular mortality: glycemic regulation, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (inversely), total cholesterol, creatinine, and macroalbuminuria. Furthermore, all markers except macroalbuminuria were associated with IHD. Microalbuminuria at baseline was not related to any of the endpoints.

Conclusions

Glycemic regulation, dyslipidemia, and renal dysfunction were all related to mortality and IHD in a 13-year follow-up of long-term Danish type 1 diabetic patients. These results underscore the better outcome for tightly regulated type 1 diabetic patients, even in long-term survivors.

a Department of Ophthalmology, Odense University Hospital, Odense, Denmark

b Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark

c Department of Applied Research and Health Technology Assessment, Odense University Hospital, Odense, Denmark

d Epidemiology, Institute of Public Health, University of Southern Denmark, Odense, Denmark

Corresponding Author InformationCorresponding author. Department of Ophthalmology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark. Tel.: +45 6541 3196; fax: +45 6612 6387.

PII: S1056-8727(09)00050-6

doi:10.1016/j.jdiacomp.2009.05.003


View previous. 3 of 12 View next.

Advertisement